Use of Markov series and Monte Carlo simulation in predicting replacement valve performances

Journal of Heart Valve Disease

Volumn 7, Issue 1, 1998, Pages 4-12

  De Kruyk, A Rob ^a   Van Der Meulen, Jan H P ^b,d   Van Herwerden, Lex A ^c   Bekkers, Jos A ^c   Steyerberg, Ewout W ^a   Dekker, Rommert ^a   Habbema, J Dik F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR RISK; HUMAN; LIFE EXPECTANCY; MODEL; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SIMULATION; SYSTEM ANALYSIS;

ADULT; AORTIC VALVE; BIOPROSTHESIS; CAUSE OF DEATH; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; MONTE CARLO METHOD; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031933277     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg 1960;40:744-762
2. Starr A, Edwards ML, McCord CW, Griswold HE. Aortic replacement: Clinical experience with a semi-grid ball-valve prosthesis. Circulation 1963;27:779-783
3. Edmunds LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987;44:430-445
4. Van der Meulen JHP, Steyerberg EW, Van der Graaf Y, Van Herwerden LA, Verbaan CJ, Defauw JJAMT, Habbema JDF. Age thresholds for prophylactic replacement of Björk-Shiley convexo-concave heart valves: A clinical and economic evaluation. Circulation 1993;88:156-164
5. Grunkemeier GL, Chandler JG, Miller DC, Jamieson WRE, Starr A. Utilization of manufacturers' implant card data to estimate heart valve failure. J Heart Valve Dis 1993;2:493-503
6. Beck JR, Pauker SG. The Markov process in medical prognosis. Medical Decision Making 1983;3:419-458
7. Habbema JDF, Van Oortmarssen GJ, Lubbe JThN, Van der Maas PJ. The MISCAN simulation program for the evaluation of screening for disease. Comp Method Prog Biomed 1984;20:79-93
8. Jamieson WRE, Rosado LJ, Munro AI, Gerein AN, Burr LH, Miyagishima RT, Janusz MT, Tyers GFO. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg 1988;46:155-162
9. O'Brien MF, McGiffin DC, Stafford EG, Gardner MAH, Pohlner PF, McLachlan GJ, Gall K, Smith S, Murphy E. Allograft aortic valve replacement: Long-term comparative clinical analysis of the viable cryop-reserved and antibiotic 4° stored valves. J Card Surg 1991;6(suppl.4):534-543
10. Bodnar E, Wain WH, Martelli V, Ross DN. Long term performance of 580 homograft and autograft valves used for aortic valve replacement. Thorac Cardiovasc Surg 1979;27:31-38
11. O'Brien MF, Stafford EG, Gardner MAH, Pohlner PG, McGiffin DC, Kirklin JW. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-823
12. Matsuki O, Okita Y, Almeida RS, McGoldrick JP, Hooper TL, Robles A, Ross DN. Two decades' experience with aortic valve replacement with pulmonary autograft. J Thorac Cardiovasc Surg 1988;95:705-711
13. Rutledge R, Kim BJ, Applebaum RE. Actuarial analysis of the risk of prosthetic valve endocarditis in 1,598 patients with mechanical and bioprosthetic valves. Arch Surg 1985;120:469-472
14. Akins CW. Mechanical cardiac valvular prostheses. Ann Thorac Surg 1991;52:161-172
15. Kinsley RH, Antunes MJ, Colsen PR. St. Jude Medical valve replacement. J Thorac Cardiovasc Surg 1986;92:349-360
16. Burckhardt D, Striebel D, Vogt S, Hoffmann A, Roth J, Weiss P, Kiowski W, Pfisterer M, Burkart F, Althaus U, Goy JJ, Sadeghi H, Gradel E. Heart valve replacement with St. Jude Medical valve prosthesis: Long-term experience in 743 patients in Switzerland. Circulation 1988;78(suppl.I):I18-I24
17. Hammermeister KE, Henderson WG, Burchfiel CM, Sethi GK, Souchek J, Oprian C, Cantor AB, Folland E, Khuri S, Rahimtoola S. Comparison of outcome after valve replacement with a bioprosthesis versus a mechanical prosthesis: Initial 5 year results of a randomized trial. J Am Coll Cardiol 1987;10:719-732
18. Lindblom D. Long-term clinical results after aortic valve replacement with the Björk-Shiley prosthesis. J Thorac Cardiovasc Surg 1988;95:658-667
19. Hammond GL, Geha AS, Kopf GS, Hashim SW. Biological versus mechanical valves. J Thorac Cardiovasc Surg 1987;93:182-198
20. Nakano K, Imamura E, Hashimoto A, Aosaki M, Endo M, Hayashi H, Koyanagi H. Six-year experience with the St. Jude Medical prosthesis: Early and late results of 540 valves in 462 patients. Jap Circ J 1987;51:275-283
21. Jamieson WRE, Gerein AN, Tyers GFO, Janusz MT, Munro AI, Jyrala AJ, Miyagishima RT, Allen P. Carpentier-Edwards supra-annular porcine bioprosthesis: Clinical experience and implementation characteristics. J Thorac Cardiovasc Surg 1986;91:555-565
22. Jamieson WRE, Miyagishima RT, Munro AI, Burr LH, Janusz MT, Ling H, Hayden RI, Tutassura H, Gerein AN, MacNab J, Chan F, Poostizadeh A, Tyers GFO. The Carpentier-Edwards supra-annular porcine bioprosthesis: Clinical performance to 8 years of a new generation porcine bioprosthesis. J Card Surg 1991;6:562-567
23. Baudet EM, Oca CC, Roques XF, Laborde MN, Hafez AS, Collot MA, Ghidoni IM. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis: Early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985;90:137-144
24. Acar J, Enriquez-Sarano M, Farah E, Kassab R, Tubiana P, Roger V. Recurrent systemic embolic events with valve prosthesis. Eur Heart J 1984;5(suppl. D):33-38
25. Duncan JM, Cooley DA, Reul GJ, Ott DA, Hallman GL, Frazier OH, Livesay JJ, Walker WE, Adams PR. Durability and low thrombogenicity of the St. Jude Medical valve at 5-year follow-up. Ann Thorac Surg 1986;42:500-505
26. Horstkotte D, Körfer R, Seipel L, Bircks W, Loogen F. Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation 1983;68(suppl. II):II175-II184
27. Janatuinen MJ, Vanttinen EA, Rantakokko V, Inberg MV. Early and late results of aortic valve replacement: A series of 510 patients. Scand J Thorac Cardiovasc Surg 1991;25:119-125
28. Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation 1985;72:753-767
29. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. John Wiley, New York, 1980:23
30. Ivert TSA, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LAL. Prosthetic valve endocarditis. Circulation 1984;69:223-232
31. Maandstatistiek van de Bevolking. Centraal Bureau voor de Statistiek, Voorburg, December 1991
32. Van der Graaf Y, De Waard F, Van Herwerden LA, Defauw J. Risk of strut fracture of Björk-Shiley valves. Lancet 1992;339:257-261
33. Kouchoukos NT, Davila-Roman VG, Spray TL, Murphy SF, Perrillo JB. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N Engl J Med 1994;330:1-6
34. Kirklin JW, Barratt-Boyes BG. Cardiac Surgery. Churchill Livingstone, New York, 1993:510